Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy is effective for tracking treatment progress in hair loss when used by an experienced doctor.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Tofacitinib is a promising treatment for children with rheumatic diseases.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib may help treat severe hair loss, but more research is needed.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.